Recombinant Monkeypox Virus Stock (1 x 1mL)

This product is intended to aid laboratories in the evaluation of nucleic acid tests designed to detect certain portions of the Monkeypox virus genome. Monkeypox virus stock provides laboratories with a targeted, reliable control for PCR testing. It is the only ready-to-use, full-process molecular control for Monkeypox.

Recombinant Monkeypox stock is formulated with purified, intact bacterial cells containing synthetic Monkeypox virus sequence to a target concentration of 1,000,000 cp/mL. The sequence includes portions of the E9L, G2R, B2R, and C3L gene regions, and the cells have been chemically modified to render them non-infectious and refrigerator-stable.

• Organisms are chemically modified to render them noninfectious
• Refrigerator stable—store between 2 and 8°C
• 1.0 mL vial

Reach out to our team today if you have any questions about Recombinant Monkeypox Virus Stock (1 x 1mL).

*Pat.: http://www.zeptometrix.com/patent-information/

NATtrol™ Recombinant Monkeypox Stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of Monkeypox virus DNA. NATtrol™ Recombinant Monkeypox Virus Stock enables laboratories to monitor test variation, lotto-lot test kit performance, and operator variation and can assist in identifying the random or systematic errors.

• ENGLISH (PI)
• ENGLISH (SDS)

For Research Use Only. Not for use in diagnostic procedures. Quality control materials should be used following local, state, federal, and accreditation requirements. This product is not intended to replace the manufacturer's controls provided with the assay. Propagation or commercialization is prohibited without prior written consent from Antylia Scientific.

When used as a control for nucleic acid tests, the same protocols as those used to amplify extracted clinical specimens should be employed.

The suitability and performance characteristics should be determined by your laboratory for each intended usage.